Literature DB >> 28246129

Low Sodium Diet, Vitamin D, or Both for RAASi-Resistant, Residual, Proteinuria in CKD? The ViRTUE Trial Points the Way Forward but Is Not the Last Word.

David Goldsmith1,2, Ravi I Thadhani3,4.   

Abstract

Entities:  

Keywords:  Trial; Vitamin D; proteinuria

Mesh：

Substances：

Year:  2017        PMID： 28246129      PMCID： PMC5373469          DOI： 10.1681/ASN.2016121321

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  27 in total

1.  Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome.

Authors:  I S Hoffmann; L X Cubeddu
Journal:  J Hum Hypertens       Date:  2007-02-01       Impact factor: 3.012

2.  Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Authors:  Dick de Zeeuw; Rajiv Agarwal; Michael Amdahl; Paul Audhya; Daniel Coyne; Tushar Garimella; Hans-Henrik Parving; Yili Pritchett; Giuseppe Remuzzi; Eberhard Ritz; Dennis Andress
Journal:  Lancet       Date:  2010-11-06       Impact factor: 79.321

3.  Albuminuria induces a proinflammatory and profibrotic response in cortical collecting ducts via the 24p3 receptor.

Authors:  Eva Dizin; Udo Hasler; Stellor Nlandu-Khodo; Marc Fila; Isabelle Roth; Thomas Ernandez; Alain Doucet; Pierre-Yves Martin; Eric Feraille; Sophie de Seigneux
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-24

4.  Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate.

Authors:  Rajiv Agarwal; Jennifer E Hynson; Tyler J W Hecht; Robert P Light; Arjun D Sinha
Journal:  Kidney Int       Date:  2011-06-29       Impact factor: 10.612

Review 5.  Endothelin in nondiabetic chronic kidney disease: preclinical and clinical studies.

Authors:  Geoff J Culshaw; Iain M MacIntyre; Neeraj Dhaun; David J Webb
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

Review 6.  Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View.

Authors:  Linda F Fried; Julia Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

7.  Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

Authors:  Steven Fishbane; Harini Chittineni; Michal Packman; Paula Dutka; Nicole Ali; Nicole Durie
Journal:  Am J Kidney Dis       Date:  2009-07-12       Impact factor: 8.860

Review 8.  Cardiovascular risk prediction in people with chronic kidney disease.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-11       Impact factor: 2.894

9.  Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.

Authors:  Maartje C J Slagman; Femke Waanders; Marc H Hemmelder; Arend-Jan Woittiez; Wilbert M T Janssen; Hiddo J Lambers Heerspink; Gerjan Navis; Gozewijn D Laverman
Journal:  BMJ       Date:  2011-07-26

Review 10.  Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.

Authors:  Gemma Currie; Alison H M Taylor; Toshiro Fujita; Hiroshi Ohtsu; Morten Lindhardt; Peter Rossing; Lene Boesby; Nicola C Edwards; Charles J Ferro; Jonathan N Townend; Anton H van den Meiracker; Mohammad G Saklayen; Sonia Oveisi; Alan G Jardine; Christian Delles; David J Preiss; Patrick B Mark
Journal:  BMC Nephrol       Date:  2016-09-08       Impact factor: 2.388
View more
  1 in total

1.  Rationale and design of a placebo controlled randomized trial to assess short term, high-dose oral cholecalciferol on select laboratory and genomic responses in African Americans with hypovitaminosis D.

Authors:  Keith C Norris; M Edwina Barnett; Yuan-Xiang Meng; David Martins; Susanne B Nicholas; Gary H Gibbons; Jae Eun Lee
Journal:  Contemp Clin Trials       Date:  2018-07-18       Impact factor: 2.261
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.